Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-15-068282
Filing Date
2015-11-27
Accepted
2015-11-27 13:15:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A v425770_s3a.htm S-3/A 281585
2 EXHIBIT 4.3 v425770_ex4-3.htm EX-4.3 337060
3 EXHIBIT 4.4 v425770_ex4-4.htm EX-4.4 360700
4 EXHIBIT 12.1 v425770_ex12-1.htm EX-12.1 27986
5 GRAPHIC tlogo.jpg GRAPHIC 26185
  Complete submission text file 0001144204-15-068282.txt   1044738
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-208004 | Film No.: 151257773
SIC: 2836 Biological Products, (No Diagnostic Substances)